F. Chung (London, United Kingdom), G. Joos (Ghent, Belgium)
Effects of CXCR2 antagonists on neutrophil chemotaxis from COPD patients L. Stevens, S. Summerhill, I. Kilty, M. Yeadon, L. E. Donnelly (Sandwich, London, United Kingdom)
| |
Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in COPD B. Grensemann, B. Sibbing, D. Jungck, K. Urban, E. Stoelben, J. Strauch, J. Knobloch, A. Koch (Cologne, Germany)
| |
Corticosteroids and beta2-agonists regulate pathologic homeostasis of hyaluronic acid in human airway smooth muscle cells from patients with asthma and COPD. Therapeutic relevance E. Papakonstantinou, I. Klagas, G. Karakiulakis, M. Tamm, M. Roth (Thessaloniki, Greece; , Switzerland)
| |
Roflumilast N-oxide (RNO) attenuates epithelial-mesenchymal transition (EMT) in differentiated human bronchial epithelial cells (D-HBE) J. Milara, T. Peiró, A. Serrano, E. Morcillo, J. Cortijo (Madrid, Spain)
| |
Effects of long-acting β2 agonist on cytokine expression in human plasmacytoid dendritic cells C. H. Hung (Taiwan)
| |
Response of novel pan-JAK inhibitor in COPD peripheral blood mononuclear cells L. Stevens, A. Barnard, W. Liu, I. Kilty, M. Yeadon (Sandwich, United Kingdom)
| |
Oxidative stress and autoimmunity in COPD P. Kirkham, I. Adcock, F. Chung, P. Barnes, K. Triantaphyllopoulos, Y. Khan, G. Caramori (United Kingdom; Ferrara, Italy)
| |
Adenosine contracts human isolated bronchi via A1 receptor dependent mechanism L. Calzetta, M. G. Matera, C. P. Page, M. Cazzola, D. Spina (Rome, Italy; , United Kingdom)
| |